Title: Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal
Abstract: Journal Article Brodalumab and ixekizumab, anti‐interleukin‐17‐receptor antibodies for psoriasis: a critical appraisal ORIGINAL ARTICLE: Papp KA, Leonardi C, Menter A et al. Brodalumab, an anti‐interleukin‐17‐receptor antibody for psoriasis. N Engl J Med 2012; 366: 1181–9.ORIGINAL ARTICLE: Leonardi C, Matheson R, Zachariae C, et al. Anti‐interleukin‐17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 2012; 366: 1190–9. Get access Ph. I. Spuls, Ph. I. Spuls Department of Dermatology, University of Amsterdam, PO Box 22700, 1100 DD Amsterdam, The Netherlands Search for other works by this author on: Oxford Academic Google Scholar L. Hooft L. Hooft Dutch Cochrane Centre, Academic Medical Centre, University of Amsterdam, PO Box 22700, 1100 DD Amsterdam, The Netherlands E‐mail: [email protected] Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 167, Issue 4, 1 October 2012, Pages 710–713, https://doi.org/10.1111/bjd.12025 Published: 01 October 2012
Publication Year: 2012
Publication Date: 2012-09-26
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 44
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot